Stepwise OPD Management of Darkening of Lips (Lip Hyperpigmentation)

Step 1 - History Taking

• Lifelong vs. acquired (recent onset is more concerning)
• Sudden onset vs. gradual progressive darkening

• Discrete macules vs. diffuse darkening
• Single spot vs. multiple spots
• Location: vermilion border, mucosal lip, perioral skin, or all three

• Abdominal pain, GI bleeding, or polyps (Peutz-Jeghers syndrome)
• Fatigue, weight loss, postural dizziness (Addison's disease)
• Cardiac symptoms - palpitations, murmur (LEOPARD/Carney complex)
• Family history of similar pigmentation or syndromes

• Antimalarials (hydroxychloroquine, chloroquine)
• Chemotherapy agents
• Minocycline
• Oral contraceptive pills
• Antiretrovirals (zidovudine, lamivudine)
• PUVA therapy
• Heavy metals (bismuth, lead, mercury)

• Smoking ("smoker's melanosis" - diffuse pale-to-dark-brown pigmentation)
• Sun exposure habits
• Dental amalgam exposure

• Pregnancy (lentigines may become more conspicuous during pregnancy)
• Menstrual irregularities (Addison's)

Step 2 - Clinical Examination

• Vermilion border: most common site for labial melanotic macule (lentigo)
• Buccal mucosa, gingiva, palate: rule out oral melanosis
• Perioral skin: look for perioral spotting (Peutz-Jeghers)

• Mucosal lentigines show a fingerprint pattern with narrow parallel lines and broader track-like pigmentation interrupted by dots and globules
• Look for irregular structureless areas or atypical vascular patterns (red flags for melanoma)

• Irregular/asymmetric borders
• Mottled non-homogeneous pigmentation
• Rapid increase in size
• Ulceration or bleeding
• Raised/nodular component

• Multiple lentigines on face, trunk, palms, genitalia (LEOPARD/Carney/Laugier-Hunziker)
• Nail pigmentation (Laugier-Hunziker syndrome)
• Diffuse skin hyperpigmentation (Addison's disease)
• Acanthosis nigricans
• Oral/perianal mucosal involvement

Step 3 - Differential Diagnosis

Step 4 - Investigations

• Routine blood counts, serum electrolytes (Na+, K+), fasting blood glucose
• Morning serum cortisol + ACTH stimulation test if Addison's disease is suspected
• Thyroid function tests (TFTs) if Carney complex suspected

• Refer for upper GI endoscopy and colonoscopy
• Genetic counseling

• Any solitary acquired lesion with irregular features, rapid growth, or atypical dermoscopy
• Lesions >1 cm, nodular, ulcerated, or bleeding
• Mottled, non-homogeneous pigmentation that cannot be distinguished from melanoma
• Remember: 30-60% of oral cavity melanomas are preceded by months-to-years of melanosis (Dermatology 2-Volume Set 5e) - a low threshold for biopsy is justified

Step 5 - Management

• If benign labial melanotic macule is confirmed, reassure the patient - it is entirely benign with no risk of malignant transformation
• Explain that the lesion may slowly change in size/pigmentation over years without becoming dangerous
• Avoidance of sun exposure and UV radiation does NOT prevent or reduce lentigo simplex

• Drug-induced: Discontinue the offending drug if medically feasible; pigmentation gradually fades
• Smoker's melanosis: Smoking cessation; pigmentation typically improves
• Addison's disease: Refer endocrinology; adrenal steroid replacement resolves mucosal pigmentation
• Peutz-Jeghers / LEOPARD / Carney complex: Refer relevant specialty for systemic management; lip pigmentation itself is managed conservatively
• Amalgam tattoo: No treatment needed; observe

1. Cryotherapy - superficial freeze; simple, office-based procedure
2. Q-switched (QS) Nd:YAG laser or Q-switched alexandrite laser - effective for melanin-targeted destruction of labial lentigines; preferred for cosmetically sensitive sites like the lip
3. Intense Pulsed Light (IPL) - can be used for superficial pigmentation
4. Topical depigmenting agents (limited role on vermilion/mucosal surfaces; more applicable to perioral skin):
   • Hydroquinone 2-4%
   • Tretinoin
   • Azelaic acid
   • Kojic acid
   • Sunscreen (SPF 30+) for perioral skin pigmentation

• Sunscreen application to perioral and lip area (SPF 30+, broad-spectrum)
• Use of lip balm with UV protection
• Limit UV exposure between 10 am-4 pm (for perioral/skin component)

Step 6 - Follow-Up

• Stable benign lesions (labial melanotic macule): Annual review; document with photography or dermoscopy
• Monitor for change: Any increase in size, new irregularity, darkening, or bleeding - biopsy immediately
• Post-treatment (laser/cryo): Review at 4-6 weeks for response; retreatment may be needed
• Systemic causes (Addison's, Peutz-Jeghers): Follow up with relevant specialty as per their disease protocol

Summary Flowchart

Darkening of lips
       |
History + Examination + Dermoscopy
       |
       ├── Multiple lesions + systemic features → Investigate for syndrome (Peutz-Jeghers, LEOPARD, Addison's, Carney)
       ├── Drug history → Stop drug, monitor for fading
       ├── Smoking → Cessation counseling
       ├── Solitary/few lesions, no systemic features → Labial melanotic macule (lentigo) - most likely
       |       |
       |       ├── Benign features → Reassure, cosmetic Rx if desired (laser/cryo)
       |       └── Atypical features → Biopsy to exclude melanoma
       └── Any doubt about malignancy → Biopsy without delay

• Dermatology 2-Volume Set 5e (Bolognia), Chapter 112 - Lentigines, Lentigenosis and associated syndromes (p. 2358-2361)
• Fitzpatrick's Dermatology 9e, Chapter 115 - Lentigo Simplex (p. 1998-1999)
• Harrison's Principles of Internal Medicine 22E, Table 38-2 - Pigmented Lesions of the Oral Mucosa (p. 307)
• Andrews' Diseases of the Skin Clinical Atlas 2e - Melanocytic lesions of the oral cavity

Stepwise OPD Management: Acquired Lip Darkening in a 28-Year-Old Female

Why Age + Sex + Acquired Onset Matters

Step 1 - Focused History

• Exactly when did it start? How fast did it develop?
• Any preceding redness, swelling, or itching at the lip before darkening appeared? (suggests PIH)
• Is it getting darker, stable, or fading?

• Is she on oral contraceptive pills (OCPs)? Since when?
• Any recent pregnancy or planning pregnancy?
• Menstrual regularity - rule out PCOS, adrenal dysfunction

• Antimalarials (hydroxychloroquine)
• Minocycline / doxycycline (for acne)
• Phenytoin
• Antiretrovirals
• Ask specifically about OCPs (dual role - both hormonal trigger for melasma AND direct drug pigmentation)

• Does the pigmentation worsen in summer or after sun exposure? (melasma pattern)
• Occupation - outdoors?

• Habitual lip licking, biting, or sucking (frictional PIH)
• Smoking (smoker's melanosis)
• Use of toothpaste with fluoride/sodium lauryl sulfate causing contact cheilitis → PIH
• Lip balm or cosmetic product application (contact allergy → PIH)

• Steroid creams (if any - exogenous ochronosis possible with prolonged use)
• Fairness creams containing mercury or hydroquinone on adjacent skin

• Fatigue, weakness, weight loss, nausea, postural dizziness, increased thirst

Step 2 - Clinical Examination

• Location exactly: Vermilion border only vs. mucosal surface vs. perioral skin vs. all three
• Distribution: Focal single macule vs. diffuse darkening vs. multiple discrete spots
• Color: Brown (epidermal) vs. gray-blue (dermal) - helps predict response to treatment
• Borders: Sharp vs. ill-defined
• Surface: Flat/macular only - any induration, nodularity, or ulceration (red flag)

• Epidermal melanin: enhanced (brighter) under Wood's lamp
• Dermal melanin: NOT enhanced - appears same or less distinct
• Mixed pattern: partially enhanced
• This guides prognosis - epidermal pigment responds better to topical therapy

• Labial melanotic macule: fingerprint pattern, parallel lines, dots and globules
• Atypical vascular pattern, irregular structureless areas = biopsy immediately

• Malar/forehead pigmentation → melasma
• Perioral hyperpigmentation with facial distribution → melasma, lichen planus pigmentosus

• Diffuse skin hyperpigmentation + buccal pigmentation → Addison's
• Nail pigmentation → Laugier-Hunziker (idiopathic, benign)
• Palmar/plantar spots → Peutz-Jeghers (unlikely at this age without childhood history)

Step 3 - Investigations

• Hemogram (CBC) - rule out nutritional deficiencies (B12, folate)
• Serum B12, folate levels (deficiency → hyperpigmentation)
• Thyroid function tests (TSH, fT4)

• Morning serum cortisol (8 AM)
• ACTH stimulation test (250 µg Synacthen)
• Serum Na+, K+ (hyponatremia + hyperkalemia in Addison's)

• Drug withdrawal trial (if medically safe)

• Consider stopping OCP and reassessing after 3-6 months (note: melasma from OCP may persist for years even after stopping)

• Any lesion with irregular borders, rapid enlargement, raised component, or atypical dermoscopy
• Rule out melanoma - even though rare at 28, mucosal melanoma is aggressive and cannot be missed
• Histology of labial melanotic macule: acanthosis, broad rete ridges, basilar hyperpigmentation, slight melanocytic hyperplasia, melanophages, NO atypia

Step 4 - Establish Diagnosis and Subtype

• Labial melanotic macule, melasma (epidermal type), early PIH
• Best response to topical depigmenting agents

• Post-inflammatory dermal melanosis (melanin dropout), drug-induced dermal pigmentation
• Poor response to topicals; laser may help

• Most melasma cases are mixed
• Moderate response; combination approach needed

Step 5 - Management (Stepwise)

5A. Counseling (Always First)

• Explain the chronic and relapsing nature of acquired lip pigmentation - especially if melasma
• Set realistic expectations: pigmentation lightens but may not fully clear
• Warn that pregnancy, sun exposure, and hormonal changes will worsen it
• Photodocumentation at baseline

5B. Trigger Removal (Critical Step)

• Stop or switch OCP - discuss alternative contraception with gynecologist
• Sun protection - broad-spectrum sunscreen SPF 30+ (physical blocker preferred: zinc oxide, titanium dioxide) applied to perioral area and lips daily; use even on cloudy days; visible light protection needed for skin types IV-VI
• Lip balm with UV protection (SPF 15+ lip sunscreen)
• Stop habitual lip licking/biting - if this is the cause
• Avoid known triggers - lip cosmetics causing contact reactions, offending drugs
• Smoking cessation if applicable

5C. Topical Depigmenting Agents

• Hydroquinone 2-4% - gold standard; apply twice daily to affected area for 8-12 weeks; avoid mucosal surfaces
• Tretinoin 0.025-0.05% - enhances hydroquinone efficacy; use at night; increases photosensitivity so strict sun protection is mandatory

• Hydroquinone 5% + Tretinoin 0.1% + mild topical corticosteroid (fluocinolone acetonide 0.01%)
• Or commercially available triple combination (4% hydroquinone + 0.05% tretinoin + 0.01% fluocinolone)
• Apply at night; use only for 8-12 weeks; twice-weekly maintenance thereafter
• Avoid prolonged uninterrupted use - risk of exogenous ochronosis with overuse of hydroquinone

• Azelaic acid 15-20% - safe, effective, anti-inflammatory; good for darker skin types
• Kojic acid 1-4%
• Niacinamide 4-5%
• Vitamin C (ascorbic acid) 10-15% serum
• Arbutin (alpha-arbutin) - botanical, gentler

5D. Systemic Agents (For Refractory / Melasma-Predominant Cases)

• Oral tranexamic acid 250 mg twice daily (500 mg/day total) - proven efficacy for both epidermal and dermal melasma; safe; use for 3-6 months; particularly useful for treatment-resistant cases (Fitzpatrick's Dermatology 9e, Andrews')
• Screen for contraindications before prescribing: thromboembolic risk, pregnancy

5E. Procedural Options (In-Clinic - If Topicals Insufficient)

• Q-switched Nd:YAG laser (low-fluence "laser toning") - most popular; proven efficacious and safe; targets melanin; useful for both epidermal and dermal pigment
• Intense Pulsed Light (IPL) - useful for superficial epidermal pigmentation; high relapse rate
• Cryotherapy - for discrete labial melanotic macule; simple, office-based
• Superficial chemical peels - glycolic acid, salicylic acid, TCA; use as adjunct; perform with caution in darker skin types (Fitzpatrick IV-VI) due to risk of worsening PIH
• Fractional non-ablative lasers (1550 nm, 1927 nm) - for refractory cases

Step 6 - Specific Treatment by Diagnosis

Step 7 - Follow-Up Plan

• Review at 8-12 weeks after starting topical therapy to assess response
• Reassess Wood's lamp to confirm epidermal lightening
• Photograph at each visit for objective comparison
• Maintenance therapy: After initial response, switch to twice-weekly application of combination cream to prevent relapse
• Counsel: Sun re-exposure and hormonal changes WILL cause relapse - maintenance sunscreen is lifelong
• If no improvement at 12 weeks with topical therapy → refer to dermatologist for procedural options or advanced assessment
• Any change in morphology (raised, ulcerated, irregular) → urgent biopsy

OPD Management: Sun-Induced Lip Darkening in a 28-Year-Old Female

Diagnosis in Context

Step 1 - Confirm History

• When did it start? Slow progression over months-years with increasing sun exposure?
• Worsens in summer, improves slightly in winter? (characteristic of both solar lentigo and melasma)
• Outdoor exposure - duration, no hat or lip protection?
• OCP use? (if yes, melasma is the dominant diagnosis)
• Any associated facial pigmentation (forehead, malar area)?
• Skin phototype (Fitzpatrick I-VI) - darker skin types more prone to post-inflammatory worsening with treatment

Step 2 - Clinical Examination

• Solar lentigo: well-defined, irregular borders, light to dark brown macule(s); tendency to coalesce in severely sun-damaged areas (Fitzpatrick's Dermatology 9e, p. 2000)
• Size: can range from <1 mm to several cm; may coalesce

• Epidermal melanin (solar lentigo): enhances under Wood's lamp - appears brighter
• Dermal melanin: does NOT enhance
• This step is critical - epidermal pigment responds well to treatment; dermal pigment does not respond to topical bleaching agents

• Solar lentigo on lip: moth-eaten borders, fingerprint/network pattern
• Atypical features (gray structureless areas, irregular vessels) → biopsy before treating

Step 3 - Investigations

• No routine investigations needed for isolated solar lip lentigo
• Biopsy only if: atypical dermoscopy, rapid growth, raised/nodular component, or features suspicious for lentigo maligna (melanoma in situ) - which can mimic solar lentigo especially on the face
• If OCP use confirmed and pigmentation is diffuse → check TFTs, rule out thyroid-associated melasma

Step 4 - Counseling (Before Any Treatment)

1. Reassure - solar lentigo is a benign lesion with no malignant potential by itself; treatment is purely cosmetic
2. Explain that sun is the primary driver - without photoprotection, any treatment will fail or relapse
3. Warn that melasma is chronic and relapsing - "Managing expectations is critical for patient satisfaction" (Fitzpatrick's Dermatology 9e, p. 1410)
4. Explain that hydroquinone and bleaching creams do NOT work well for solar lentigo - laser/cryo are more effective (Dermatology 2-Volume Set 5e, p. 2283)
5. Warn that darker skin types (Fitzpatrick IV-VI) are at higher risk of post-treatment PIH - procedures must be done with caution

Step 5 - Treatment (Stepwise by Priority)

5A. Photoprotection - THE CORNERSTONE (Step 1 of treatment)

• Broad-spectrum sunscreen SPF 30-50+ with physical blockers (zinc oxide, titanium dioxide) applied to perioral area and lips
• Lip-specific sunscreen balm (SPF 15-30) - applied to the lips themselves; reapply every 2 hours outdoors
• Sun avoidance between 10 AM - 4 PM
• Protective clothing: wide-brimmed hats, scarves covering lower face when outdoors
• For darker skin phototypes (IV-VI): also protect from visible light (physical/tinted sunscreens) as it independently stimulates melanogenesis
• Photoprotection alone produces modest improvement in melasma and prevents new solar lentigines (Fitzpatrick's 9e, p. 2002; Andrews', p. 40)

5B. Topical Depigmenting Agents (for perioral skin / if melasma component present)

• Hydroquinone 5% + Tretinoin 0.1% + mild topical corticosteroid (fluocinolone 0.01%)
• Apply at night; strict sun protection during the day
• Use for 8-12 weeks; then twice-weekly maintenance
• Do NOT use on the moist vermilion/mucosal lip - apply only to perioral skin
• Overuse leads to exogenous ochronosis, telangiectasias - counsel patient

5C. Procedural/Physical Treatment (for solar lentigo on the lip - definitive treatment)

• Liquid nitrogen, light freeze (5-10 seconds) to the lesion
• Simple, low-cost, effective for discrete macules
• Risk: hypopigmentation (especially in darker skin) and blistering
• Caution: on the lip, short freeze time to minimize scarring/dyspigmentation

• Most effective for solar lentigo; melanin-targeted
• "Frequency doubled Q-switched Nd:YAG can lead to significant improvement" (Dermatology 5e, p. 2283)
• 1-3 sessions typically needed
• Caution: post-treatment dyspigmentation possible; pre-treat with depigmenting agent for 4-6 weeks in darker skin types

• Effective for superficial epidermal pigmentation
• High relapse rate without continued sun protection
• Not ideal on the lip vermilion; better for perioral skin

• Tretinoin 0.025-0.05% cream to perioral skin
• Slow but useful for maintenance; prevents new lesions
• Andrews' Diseases of the Skin: "Cryotherapy, topical retinoids, hydroquinone, IPL, and lasers are effective in treatment of solar lentigines" (p. 40)

• A newer competitive inhibitor of α-MSH; reduces melanogenesis
• Applied topically; useful adjunct for phototype-induced lip pigmentation

• Glycolic acid 20-70%, salicylic acid 20-30%, TCA 10-25%
• Used as adjuncts; results not reproducibly better than HQ alone
• Risk of PIH in darker skin; do with extreme caution

Step 6 - Systemic Agent (Refractory/Melasma-Dominant Cases)

• Oral tranexamic acid 250 mg BD (500 mg/day) for 3-6 months
• Proven efficacy for both epidermal and dermal melasma
• Particularly useful when topical treatment alone is insufficient
• Fitzpatrick's 9e: "When used as an adjunct in low doses (500-700 mg daily) over a few months, it is efficacious and safe in treatment-resistant cases"
• Contraindications: personal/family history of thromboembolism, pregnancy

Step 7 - Maintenance and Follow-Up

• Photograph and compare with baseline
• Wood's lamp re-examination to assess lightening of epidermal pigment
• Adjust treatment if inadequate response

• Daily sunscreen/lip SPF is lifelong - the single most important measure
• Twice-weekly application of depigmenting cream (for perioral melasma)
• Avoid sun peaks (10 AM-4 PM), wear protective gear when outdoors

• Solar lentigo is a marker of cumulative UV damage - monitor annually for other UV-related lesions (actinic keratosis, squamous cell carcinoma, melanoma) on sun-exposed skin
• Any change in morphology (nodularity, ulceration, bleeding, rapid enlargement) → immediate biopsy

Summary: Quick Reference Card

28F, Acquired, Sun-induced Lip Darkening
              ↓
Confirm solar lentigo (discrete) vs. melasma (diffuse)
              ↓
STEP 1: Photoprotection (SPF 30-50+ sunscreen + lip balm SPF 15+)
              ↓
STEP 2: Counsel — chronic condition; realistic expectations
              ↓
STEP 3: For solar lentigo → Cryotherapy OR Q-switched Nd:YAG laser
         For melasma component → HQ 4% + Tretinoin ± topical steroid (Kligman's)
         Perioral skin → Triple combination cream
              ↓
STEP 4: If refractory → Oral tranexamic acid 500 mg/day x 3-6 months
              ↓
STEP 5: Follow up 8-12 weeks; maintain sun protection lifelong

• Dermatology 2-Volume Set 5e (Bolognia), Chapter 109 - Solar Lentigo, Treatment, p. 2283
• Fitzpatrick's Dermatology 9e, Chapter 115 - Solar Lentigo Management, p. 2002; Melasma Management, p. 1410
• Andrews' Diseases of the Skin Clinical Dermatology - Ephelis and Lentigo, p. 40; Melasma, p. 993